Global Wealth Management Investment Advisory’s Artelo Biosciences, Inc. Warrant ARTLW Stock Holding History

Global Wealth Management Investment Advisory’s Portfolio ARTLW Stock Details ARTLW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-475	Closed	–	–	540
2021 Q4	$0	Buy	+475	New	+$102	﹤0.01%	512

Other funds holding ARTLW

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Global Wealth Management Investment Advisory's ARTLW Position: Q1 2022 in Review

Global Wealth Management Investment Advisory sold out of Artelo Biosciences, Inc. Warrant (ARTLW) in Q1 2022, closing a stake of 475 shares.

Global Wealth Management Investment Advisory first reported a position in ARTLW in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 4 funds tracked by Wall St. Rank hold ARTLW as of Q1 2022.

Global Wealth Management Investment Advisory reported no remaining Artelo Biosciences, Inc. Warrant position as of Q1 2022 after selling out during the quarter.
Global Wealth Management Investment Advisory sold 475 Artelo Biosciences, Inc. Warrant shares in Q1 2022.
Global Wealth Management Investment Advisory first reported a position in Artelo Biosciences, Inc. Warrant in Q4 2021 and held it in 1 quarter.
Global Wealth Management Investment Advisory's Artelo Biosciences, Inc. Warrant position peaked at $0 in Q4 2021.
4 funds tracked by Wall St. Rank held Artelo Biosciences, Inc. Warrant as of Q1 2022.

Based on Global Wealth Management Investment Advisory's 13F filing for Q1 2022, filed 17 May 2022.